The Association Between Familiarity of the Surgeon-Anesthesiologist Dyad and Post-Operative Patient Outcomes for Complex Gastro- intestinal Cancer Surgery: A Population-Based Study
Society of Surgical Oncology (SSO)
A new study identified a compound that prevents C. diff infection. Researchers are now using this compound to develop new drug candidates that might eventually offer a way to prevent serious C. diff infections.
The cystic fibrosis transmembrane conductance regulator has been studied for years but the combined efforts of St. Jude Children’s Research Hospital and Rockefeller University have yielded new insights.
Cedars-Sinai Cancer experts in the fields of pancreatic, gastrointestinal, skin and breast surgical oncology are available to share research findings and comment on the latest news coming out of the Society of Surgical Oncology 2023 International Conference on Surgical Cancer Care March 22-25 in Boston.
Along with UNC colleagues Scott Commins, MD, PhD, and Michael Croglio, MD, McGill was one of the first to describe the condition in gastroenterology patients. McGill has now published a national clinical practice update in the journal Clinical Gastroenterology and Hepatology of the American Gastroenterological Association.
The American Gastroenterological Association (AGA) has released new clinical guidance to help physicians and patients identify if unexplained digestive symptoms are due to alpha-gal syndrome, a food allergy that is caused by lone star tick bites.
Researchers at the Universities of Bonn and Singapore have discovered a new intracellular "smoke detector."
Scientists from the French National Reference Center for Escherichia coli, Shigella and Salmonella at the Institut Pasteur who have been monitoring Shigella in France for several years have detected the emergence of extensively drug-resistant (XDR) strains of Shigella sonnei.
COVID-19 is associated with an increased risk of developing long-term gastrointestinal disorders, including irritable bowel syndrome.
In experiments with mice and humans, a team led by Johns Hopkins Medicine researchers says it has identified a particular intestinal immune cell that impacts the gut microbiome, which in turn may affect brain functions linked to stress-induced disorders such as depression.
“GERD is common, affecting about 20 percent of adults in the U.S., and it can compromise quality of life and have serious, long-term health consequences if not addressed and treated properly,” said Annie Laurie Benzie, M.D., a fellowship-trained, board-certified general surgeon who leads the new program.
Twenty years ago, Kentucky had the highest colorectal cancer incidence and mortality rates in the U.S., as well as the second-lowest colorectal cancer screening rate.In collaboration with several major cancer groups, the Kentucky Cancer Consortium (KCC), housed at the University of Kentucky Markey Cancer Center, took action to make colorectal cancer screenings more accessible for Kentuckians.
Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.
In a new paper published in Science, Dana-Farber Cancer Institute researchers outline the complexities of young-onset colorectal cancer and the research needed to map out a path toward understanding it.
Keck Medicine of USC has launched a Phase 2 clinical trial investigating the effectiveness of a new outpatient, nonsurgical endoscopic procedure in stabilizing blood glucose levels for patients.
It's sleep awareness week, according to the National Sleep Foundation. It’s important to understand how sleep deprivation can impact your health. Most people recognize that if they don’t get enough sleep, their mood and memory will suffer the next day.
Um plugue absorvível entregou terapia com células-tronco com poucos efeitos colaterais em pacientes com fístulas perianais de trato único, segundo descoberta de pesquisadores da Mayo Clinic.
Los investigadores de Mayo Clinic descubrieron que un tapón soluble administró terapia con células madre ocasionando pocos efectos secundarios en pacientes con fístulas perianales de un solo trayecto.
توصّل باحثو مايو كلينك إلى إمكانية العلاج بالخلايا الجذعية عبر سدادة قابلة للذوبان لديها آثارٌ جانبية قليلة على المرضى المصابين بالناسور الشرجي أحادي السبيل. النواسير الشرجية هي ممرات مؤلمة بين الأمعاء والجلد، ولا تُشفى عادةً بالرعاية الطبية أو الجراحية القياسية. إن المصابين بداء كْرون أو غيره من حالات التهاب الأمعاء هم الأكثر عرضة لخطر الإصابة بهذه الحالة المرضية.